Direct acting antiviral has offered treatment of hepatitis C virus (HCV) recurrence post liver transplantation (LT) with an all‐oral regimen for short duration, excellent safety profile, and high sustained virological… Click to show full abstract
Direct acting antiviral has offered treatment of hepatitis C virus (HCV) recurrence post liver transplantation (LT) with an all‐oral regimen for short duration, excellent safety profile, and high sustained virological response (SVR). The aim of this study was to evaluate the efficacy and safety of sofosbuvir (SOF)‐based regimens in the real world among a cohort of Egyptian patients with recurrent HCV post living donor LT (LDLT).
               
Click one of the above tabs to view related content.